Vimarsana
Biggest News Aggregation in the World

Page 19 - Adaptive Research News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Adaptive Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Adaptive Research Today - Breaking & Trending Today

Kintara Announces Initiation of Patient Recruitment for VAL-083's Study Arm in the GBM AGILE Trial - Vimarsana News

Kintara Announces Initiation of Patient Recruitment for VAL-083's Study Arm in the GBM AGILE Trial

/PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid...

Kazia Therapeutics : commences recruitment to GBM AGILE - Vimarsana News

Kazia Therapeutics : commences recruitment to GBM AGILE

ASX RELEASE 7 January 2021 GBM AGILE PIVOTAL STUDY COMMENCES RECRUITMENT TO PAXALISIB ARM Sydney, 7 January 2021 -... | January 27, 2021

Global Coalition for Adaptive Research, Kazia, and Kintara Announce Commencement of Kazias Paxalisib and Kintaras VAL-083 in GBM AGILE Trial - Vimarsana News

Global Coalition for Adaptive Research, Kazia, and Kintara Announce Commencement of Kazias Paxalisib and Kintaras VAL-083 in GBM AGILE Trial

Posted on 288 Global Coalition for Adaptive Research (LOS ANGELES, CA), Kazia Therapeutics Limited (ASX: KZA, NASDAQ: KZIA, SYDNEY, Australia), and Kintara Therapeutics, Inc. (NASDAQ: KTRA, SAN DIEGO, CA) — The Global Coalition for Adaptive Research (GCAR) in collaboration with Kazia and Kintara, today announced the activation of Kazia’s paxalisib and Kintara’s VAL-083 in GBM AGILE (Glioblastoma Adaptive Global Innovative Learning Environment). GBM AGILE is a revolutionary patient-centered, adaptive platform trial for regis...